Finally, he is Editor in Chief of the Harvard Heart Letter and the Journal of Invasive Cardiology , a guest editor and associate editor of the Journal of the American College of Cardiology , Chief Medical Editor of Cardiology Todays Intervention , and Deputy Editor of Clinical Cardiology
In addition, in the CY 2017 OPPS/ASC final rule with comment period, we finalized a policy to allow for quarterly expiration of pass-through payment status for devices to afford a pass-through payment period that is as close to a full 3 years as possible for all pass-through payment devices (81 FR 79655)
Value cost savings over FDA-approval of finished product: If you understand the difference between FDA-approved and compounded medications, recognize that compounded versions haven't undergone the same regulatory review process, and prioritize affordability when insurance doesn't cover GLP-1s for weight loss, Yucca Health's compounded formulations offer significant cost savings
Future studies should investigate whether these findings may be replicated in larger and more diverse study samples
However, the use of this relatively new class of drugs may be associated with certain adverse effects
